What is Aston Particle Technologies?
Aston Particle Technologies operates at the intersection of material science and pharmaceutical manufacturing, providing a sophisticated one-step particle engineering solution. By utilizing a novel dry particle coating technique, the firm effectively bypasses the traditional reliance on solvents or heat, which often compromise the integrity of sensitive drug compounds. This technological edge is particularly critical for high-dose, moisture-sensitive, or heat-labile medications, offering a sustainable and cost-effective alternative to conventional processing methods. The company's market position is defined by its ability to enhance particle properties while maintaining the innate chemical stability of the active pharmaceutical ingredients, a USP that addresses significant pain points in modern drug formulation.
How much funding has Aston Particle Technologies raised?
Aston Particle Technologies has raised a total of $1.2M across 1 funding round:
Unspecified
$1.2M
Unspecified (2022): $1.2M with participation from DSW Ventures
Key Investors in Aston Particle Technologies
DSW Ventures
DSW Ventures is an early-stage venture capital firm based in the UK, focusing on innovative businesses led by talented founders. The firm invests in regional start-ups, primarily in the software, spin-outs, and consumer sectors, providing hands-on support throughout the investment process.
What's next for Aston Particle Technologies?
With this major enterprise-level funding, Aston Particle Technologies is poised to transition from its current development phase toward broader commercial scaling. The strategic roadmap likely involves expanding its manufacturing capacity and deepening its integration into global pharmaceutical supply chains. By leveraging this capital, the firm aims to refine its dry coating processes to meet the rigorous regulatory standards required for large-scale drug production. Future growth will likely focus on strategic partnerships with pharmaceutical giants seeking to optimize their formulation pipelines, thereby cementing the company's role as a critical infrastructure provider in the next generation of drug delivery systems.
See full Aston Particle Technologies company page
